LOS ANGELES, August 17, 2026, 01:12 PDT — US cash markets will open Monday at 09:30 EDT, with premarket activity already started.
- The Lakers’ planned $12.5 billion sale would set a new record for a U.S. sports transaction.
- The valuation increased by 25% compared with a $10 billion agreement reached 14 months prior.
- MSG Sports continues to show a provisional private-value gap of $3.7 billion.
Magic Johnson’s acclaim for the Los Angeles Lakers’ record sale has implications for public markets. Shares of Madison Square Garden Sports Corp. (NYSE:MSGS) closed Friday at $407.17, putting the valuation of its Knicks and Rangers holdings at nearly $9.8 billion after climbing over 6% for the week.
Ex-media executive Bob Iger and investor Joshua Kushner have reached an agreement to acquire the Lakers for $12.5 billion. The transaction is pending NBA approval and is still undergoing due diligence. Johnson stated, “Laker fans, you couldn’t have two better owners.” Reuters
The price exceeds the Lakers’ $10 billion valuation from 14 months ago by $2.5 billion. This amounts to a 25% increase, or approximately 21.1% on an annualized basis, based on the assumption that the reported valuations are directly comparable.
| US sports deal | Value | Date | Relative to Lakers offer |
|---|---|---|---|
| Los Angeles Lakers, Iger-Kushner bid | $12.5 billion | August 2026 | Record high |
| Los Angeles Lakers, Walter acquisition | $10.0 billion | 2025 | 20% less |
| Boston Celtics transfer | $6.1 billion | 2025 | 51% lower |
| Charlotte Hornets transfer | $3.0 billion | 2023 | 76% less |
The boost in the private market increased MSGS’s value, as the company holds ownership of the Knicks and Rangers. Barron’s reported that analysts estimate the combined worth of the two teams at $13 billion to $14 billion. However, MSGS shares remain below that valuation.
| MSGS valuation analysis | Input | Initial result |
|---|---|---|
| Friday’s close | $407.17 | Fell 1.41% on Friday |
| Total outstanding shares | 24.077 million | Estimated market capitalization: $9.803 billion |
| Analyst range for private-asset value | $13 billion to $14 billion | Midpoint: $13.5 billion |
| Difference at midpoint | $13.5 billion less $9.803 billion | $3.697 billion, or 27.4% |
| Gap relative to Lakers sale premium | $3.697 billion over $2.5 billion | 1.48 times |
The timeline is now set. MSG Sports submitted documents on Friday to spin off the Rangers from the Knicks. Shareholders would get shares in the newly formed Rangers entity on a pro rata basis. The deal is expected to be completed in a tax-free manner by the end of October.
The arrangement will provide investors with individual valuations for basketball and hockey. There is no assurance that either franchise will be sold. MSG Sports stated that the transaction is still subject to necessary board and league approvals.
| Operating or structural signal | Latest verified reading | Investor relevance |
|---|---|---|
| Quarterly revenue growth | 37% year over year | Growth driven by playoff ticket sales and merchandise |
| Average playoff revenue | $20.2 million per game | Highlights earnings potential over an extended postseason |
| Season-ticket renewals | Expected above 90% | Sustains recurring demand as fiscal 2027 begins |
| Rangers separation | Targeted by end-October | May reveal differences in team-specific valuations |
Chief Operating Officer Jamaal Lesane said season-ticket renewals are expected to “once again reach levels above 90%.” This is significant because MSGS saw limited profits before its recent playoff performance. Private valuations on their own are not sufficient to support dividends or share repurchases. The Wall Street Journal
| Analyst | Date | Recommendation | Price target | Upside from $407.17 |
|---|---|---|---|---|
| Curry Baker, Guggenheim | July 23 | Buy | $522 | 28.2% |
| Benjamin Swinburne, Morgan Stanley | July 15 | Overweight | $450 | 10.5% |
| Joseph Stauff, Susquehanna | June 23 | Positive | $430 | 5.6% |
The core disagreement centers on the target spread. Optimistic investors use private franchise valuations for the teams, while more conservative investors factor in discounts for Dolan’s voting control, tax implications, existing shared arena deals, and unclear monetization prospects.
Risks: The Lakers deal is subject to due diligence and NBA approval and may not proceed. MSGS might finish the separation process but not close its discount. Lower ticket sales, higher player expenses or declines in media-rights revenue could negatively affect cash flow.
The immediate focus on Monday is whether MSGS maintains its Friday closing price of $407.17 as premarket trading shows further declines. A broader test looms with the Rangers distribution and the late October target date.
